pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
ABO-505
Optic Neuropathy
$ABEO
ABEONA THERAPEUTICS INC.
0
catalysts
Phase 2
ABP-745
Gouty Arthritis (Gout)
Atom Therapeutics Co Ltd
0
catalysts
Phase 1
ABS-0871
Charcot-Marie-Tooth Disease Type II
Actio Biosciences Inc
0
catalysts
Phase 2
ABS-201
Androgenic Alopecia
← prev
page 48 of 231
next →
131
Pain
89
Neurology
1
Almirall SA
0
catalysts
Phase 1
ABSK-112
Non-Small Cell Lung Cancer
Abbisko Therapeutics Co Ltd
0
catalysts
Phase 1
ABSK-121
Bile Duct Cancer (Cholangiocarcinoma)
Abbisko Therapeutics Co Ltd
0
catalysts
Phase 2
ABSK-141
Solid Tumor
Abbisko Therapeutics Co Ltd
0
catalysts
Phase 1
ABX-1100
Pompe Disease
Aro Biotherapeutics Co
0
catalysts
Preclinical
ABX-919
Atopic Dermatitis (Atopic Eczema)
Abrax Japan
0
catalysts
Phase 1
AC-0676
Diffuse Large B-Cell Lymphoma
Accutar Biotechnology Inc
0
catalysts
Phase 1
AC-0699
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Accutar Biotechnology Inc
0
catalysts
Preclinical
AC-1
Traumatic Brain Injury
AivoCode LLP
0
catalysts
Preclinical
ACAR-198
Autoimmune Disorders
AbelZeta Inc
0
catalysts
Phase 2
ACD-440
Neuropathic Pain (Neuralgia)
AlzeCure Pharma AB
0
catalysts
Phase 2
ACDN-01
Juvenile Macular Degeneration (Stargardt Disease)
Ascidian Therapeutics Inc
0
catalysts
Phase 1
ACE-1334
Systemic Sclerosis (Scleroderma)
$MRK
Merck & Co., Inc.
0
catalysts
Phase 1
ACE-1702
Solid Tumor
Acepodia Inc
0
catalysts
Phase 2
ACE-1831
Immunoglobulin G4-Related Disease (IgG4-RD)
Acepodia Inc
0
catalysts
Phase 1
ACE-2016
Solid Tumor
Acepodia Inc
0
catalysts
Phase 1
ACE-232
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Acerand Therapeutics
0
catalysts
ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG
ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG (ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG TABLETS)
TARO
0
catalysts
ACETAMINOPHEN AND CODEINE
ACETAMINOPHEN AND CODEINE (ACETAMINOPHEN AND CODEINE)
AMNEAL PHARMS NY
0
catalysts
Phase 2
ACI-24060
Alzheimer's Disease
$ACIU
AC Immune SA
0
catalysts
Phase 1
ACLX-001
Refractory Multiple Myeloma
$ACLX
Arcellx, Inc.
0
catalysts
Preclinical
ACM-002
Amyotrophic Lateral Sclerosis
Actimed Therapeutics Ltd
0
catalysts
Phase 2
ACP-01
Vescell
Chronic Stable Angina
Hemostemix Inc
0
catalysts
Phase 2
ACP-017
Cutaneous Squamous Cell Carcinoma (cSCC)
Ascendis Pharma AS
0
catalysts
Phase 1
ACR-2316
Endometrial Cancer
$ACRV
Acrivon Therapeutics, Inc.
0
catalysts
Phase 2
ACT-001
Pediatric Diffuse Intrinsic Pontine Glioma
Accendatech Co Ltd
0
catalysts
Phase 1
ACT-101
Myasthenia Gravis
Alpha Cancer Technologies Inc
0
catalysts
